甲磺酸帕珠沙星治疗急性盆腔炎的临床研究  

Efficacy and safety Pazufloxacin Mesilate in patients with acute pelvic inflammatory disease

作　　者：程宏伟 

机构地区：[1]大连市妇幼保健院妇保科,辽宁大连116033

出　　处：《中国医疗前沿（学术版）》2008年第12期19-19,共1页China Healthcare Innovation

摘　　要：目的评价甲磺酸帕珠沙星治疗急性盆腔炎的疗效。方法选择符合诊断标准的患者90例,随机分为2组:治疗组45例,给予甲磺酸帕珠沙星100ml:0.3,静脉滴注,2次/d;对照组45例,给予常规治疗方法5%葡萄糖加青霉素钠800万U,2次d静滴;0.5%甲硝唑注射液200ml静滴,1次d。两组均治疗7d。结果治疗组、对照组的痊愈率分别是62.2%和42.2%(P<0.05)。结论甲磺酸帕珠沙星治疗急性盆腔炎安全、有效。Objective To evaluate the the effect of Pazufloxacin Mesilate on acute pelvic inflammatory disease Methods Fiftiy eight patients were randomly divided into treatment group（45cases） and control group（45cases）.The treatment group used Pazufloxacin Mesilate ,the control group used Benzylpenicillin sodium injection and metronidazole injection ,all patients treated 7 days as a course .Results The curative rates of treatment group and control group were62.0%and42.5% （P〈0.05）. Conclusion Pazufloxacin Mesilate is an effective and safe agent for treatment of patients with acute pelvic inflammatory disease.

关 键 词：甲磺酸帕珠沙星 青霉素钠 急性盆腔炎 

分 类 号：R711.33[医药卫生—妇产科学]